Login / Signup

Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.

Filippo PietrantonioSara LonardiFrancesca CortiGabriele InfanteMaria Elena ElezMarwan FakihPriya JayachandranAakash Tushar ShahMassimiliano SalatiElisabetta FenocchioLisa SalvatoreGiuseppe CuriglianoChiara CremoliniMargherita AmbrosiniJavier RosRossana IntiniFloriana NappoSilvia DamianFederica MoranoGiovanni FucàMichael OvermanRosalba Miceli
Published in: Journal for immunotherapy of cancer (2022)
A nomogram based on five easily assessable variables including ICI treatment was built to estimate the outcomes of patients with MSI-high mCRC, with the potential to assist clinicians in their clinical practice. The web-based system 'MSI mCRC Cure' was released.
Keyphrases
  • metastatic colorectal cancer
  • clinical practice
  • palliative care
  • type diabetes
  • squamous cell carcinoma
  • skeletal muscle
  • adipose tissue
  • metabolic syndrome
  • risk assessment
  • insulin resistance
  • weight loss